Monday 14 December 2015

Global Peptide Therapeutics Market to be Fueled by Increasing Prevalence of Cancer and Diabetes

According to a new market study released by Transparency Market Research (TMR), the global peptide therapeutics market will be valued at US$23.7 bn by 2020, increasing from its 2013 valuation of US$18.9 bn. If the projected figure hold true, the market will rise at a moderate 2.8% CAGR from 2014 to 2020. The report is titled “Peptide Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020” and is available for sale on the company website.
Browse the full  Peptide Therapeutics Market (by Applications, by Route of Administration, and by Marketing Status) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020 report at http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Therapeutic peptides have received acceptance in the treatment of several diseases such as metabolic disorders, cancer, nervous system disorders, gastrointestinal disorders, acromegaly, hematological disorders, cardiovascular disorders, infections, and respiratory disorders, among others. Due to the efficacy of peptides for the treatment of a large number of medical conditions, further research and development has resulted in a rich pipeline of novel peptides that deliver better therapeutic effects.
Though animal sources such as venom constitute the major source for peptide research, microbial sources are also being examined for their efficacy for treatment of various medical conditions. The growing variety of sources as well as applications of peptide therapeutics is boosting growth prospects of the global peptide therapeutics market. However, despite extensive research, oral administering of therapeutic peptides still remains a challenge for researchers, which is indirectly hampering the peptide therapeutics market. Unfavorable physiological conditions such as the presence of proteolytic enzymes and acidic pH pose a challenge for oral administering of peptide therapeutics. Moreover, low intestinal penetrability of peptides also adds to the low bioavailability of these substances.
Lately, a strong trend has been observed in the peptide therapeutics market: whilst new peptide therapeutic drugs receive regulatory permission, several older peptide therapeutic drugs will go off-patent during the forecast period. In addition, difficulties associated with imitating the precise effects of biologics are a major reason for generic drug manufacturers to face drug approval issues. Thus, generic peptide therapeutic drugs are priced only 70-80% as much as branded peptide therapeutics. Due to this price gap, high demand for generic versions is expected to help the peptide therapeutics market overcome its restraints.
Presently, the generic peptide therapeutic leuprolide is retailed under the brand names Eligard, Lupron, and Enantone, of which Lupron and Enantone constitute sales over US$800 mn across the world.On the competitive front, currently, Teva Pharmaceutical Industries Ltd., Novo Nordisk, and Takeda Pharmaceutical Co. Ltd. collectively account for more than 50% of the global peptide therapeutics market. However, the patent expiration of Copaxone in 2014 and Velcade in 2017 will lead to launch of their generic alternatives. Some other prominent players in the global peptide therapeutics market are AstraZeneca plc, Eli Lilly & Co., Merck & Co., Novartis International, and AbbVie Inc.
The global peptide therapeutics market has been segmented as below:
  • Global Peptide Therapeutics Market, by Application
    • Cancer
      • Zoladex (goserelin)
      • Velcade (bortezomib)
      • Lupron/ Enantone/ Eligard (leuprorelin)
      • Others
    • Cardiovascular
      • Angiomax (bivalirudin)
      • Integrilin (eptifibatide)
    • Central Nervous System
      • Copaxone (glatiramer)
    • Metabolic Disorders
      • Victoza (liraglutide)
      • Byetta (exenatide)
      • Others
    • Infection
      • Incivek (telaprevir)
      • Victrelis (boceprevir)
    • Hematological Disorders
      • Firazyr (icatibant)
      • Kalbitor (ecallantide)
    • Gastrointestinal Disorders
      • Gattex (teduglutide)
      • Linzess (linaclotide)
    • Respiratory Disorders
    • Acromegaly
    • Other Applications
  • Global Peptide Therapeutics Market, by Route of Administration
    • Parenteral
    • Oral
  • Global Peptide Therapeutics Market, by Marketing Status
    • Branded
    • Generic
  • Global Peptide Therapeutics Market, by Geography
    • North America
    • Europe
    • Asia Pacific
    • Rest of the World
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Mr. Sudip. S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.comWebsite: http://www.transparencymarketresearch.com/

Monday 22 June 2015

Psoriatic Arthritis Pharmacotherapy Market Segment Forecasts up to 2020, Research Reports- TransparencyMarketResearch

Psoriatic Arthritis is a type of chronic inflammatory arthritis that primarily affects toes and fingers followed by nail or skin psoriasis. The clinical features are varied but the major symptoms are peripheral arthritis, enthesitis, psoriasis, dactylitis and axial disease. According to Arthritis Foundation, the prevalence of psoriatic arthritis in patients suffering from psoriasis is approximately between 7% and 48%. Psoriatic arthritis appears most often between the age of 30 years and 50 years. The factors contributing to the pathogenesis of psoriatic arthritis are genetic factors, environmental factors and immunological factors. Genetic factors explain that 40% of the psoriatic arthritis has family history of skin and joint diseases. Environmental factors such as bacterial and viral infections have been implicated as a cause in psoriatic arthritis. Immunological factors consist of cytokines such as TNF-α which is critically involved in inflammatory process, leading to bone and cartilage degradation as well as skin inflammation. There are five different types of psoriatic arthritis that includes different joints and spinal column. There are two types of method by which psoriatic arthritis is diagnosed by imaging and laboratory test. Imaging tests consist of X-Rays and magnetic resonance imaging and laboratories consists of rheumatoid factor and joint fluid test.


The pharmacotherapy of psoriatic arthritis consists of drugs such as DMARDs (disease modifying anti-rheumatic drugs), NSAIDs, Immunosuppressant and TNF-α inhibitors. In chronic conditions surgeries and other procedures are practiced such as steroid injections and joint replacement surgery. The DMARDs consists of drug that reduces the progression of psoriatic arthritis and protect joints and other tissues from irreversible damage, it includes drugs such as methotrexate, sulfasalazine and leflunomide. The NSAIDs help to relive the pain and reduction of inflammation and most of them are OTC drugs including Ibuprofen and naproxen sodium. While immunosuppressant helps to control the immune system including azathioprine and cyclosporine. TNF-α inhibitors assist reducing pain, swollen joints and morning stiffness this class of drug includes etanercept, infliximab, adalimumab, Humira, certolizumab and golimumab.

Some of the major factors driving the psoriatic arthritis market are rising geriatric population, increasing incidences of psoriatic arthritis and major onset for growth in this market is expected from the launch of blockbuster drugs such as Simponi and Vicodin along with many impending biologics that are in late stage of development. The major factors restraining the growth of psoriatic arthritis pharmacotherapy market are the new biologics that are observed to be highly efficient but come with high cost. Lack of patient awareness is one of the major factor affecting the growth of psoriatic arthritis pharmacotherapy market according to CDC (Center of Disease Control and Prevention) nearly 10% - 12% of the patients visit clinics during the chronic stage of psoriatic arthritis as most of them ignore initial symptoms which are very common like skin reddening along with a joint pain or a skin rash.

North America was observed to be the leading geography due to high prevalence of psoriatic arthritis followed by availability of modern healthcare facilities is assisting the growth of this market. Europe is the second largest market for psoriatic arthritis pharmacotherapy as it’s the region expected to observe rapid aging population. Asia-Pacific and Rest of the World are the most attractive and growing markets in psoriatic arthritis pharmacotherapy. In Asia-Pacific China, India, Japan, South Korea and Australia are observed to be the leading geographies in psoriatic arthritis.

The psoriatic arthritis pharmacotherapy market is predominantly led by the players such as Pfizer, Inc., Amgen, Inc., Merck & Co, Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Abbott Laboratories and Novartis International AG. It was observed that Abbott Laboratories, Johnson and Johnson and Amgen, Inc. account for the major market share in psoriatic arthritis pharmacotherapy.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America
This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Pharmaceutical Market: 

About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying: 



Contact Us

Mr. Nachiket Ghumare
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States.

Browse market research blog:
https://pharmaceuticalmarket.wordpress.com/

Monday 23 March 2015

Power Banks Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

A portable charger used to charge a wide range of digital product is called power bank. Power bank is also called battery charger. It is used as back-up charger, an external battery or plug-in charger for charging battery cells or rechargeable battery. Power bank is a suitable way to charge electronic device whenever and wherever needed. Mobile devices, digital cameras, laptops and tablets can be charged using power bank. The power bank is designed on the basis of device being charged. Power bank can be re-used and recharged. Milliampere-hour is the measuring unit for the capacity of power bank. Higher Milliampere results in the higher storing capacity of power banks. 

Browse Full Report with TOC:

Power bank comprise of lithium batteries as they are affordable, compact in nature and widely available. A power bank is different from each other even though the battery capacity is exactly the same; in terms of compatibility, pricing, cell quality, internal design, size and cell grade. Power bank batteries are categorized as cylindrical battery, square aluminum case and polymer battery. Due to the high mechanized cost for battery cell made of Lithium-Polymer comparing it to Lithium-Ion, the price of power bank made of Lithium-Polymer battery is higher than the power bank comprise with Lithium-Ion battery. Casing made from standard shell offer protection from any leakage or harm from the power bank. A power bank in general will require 5V/1A for optimum charging period across the globe. Power bank quality, cell PCB board design, actual capacity and reliability are factors determining approximately device charge per cycle.


Mobility and versatility are the most important features of power bank. Power bank are available in various sizes, shapes, capacities and colors. Global power bank market can be segmented on the basis of application and product type. Mobile phone chargers and Electric vehicle chargers are segments of applications. Solar power bank, power bank with LED and built-in rechargeable line are segments of power bank products.

Improved living standards, increased consumer purchasing power and rising economies are uplifting electronics market. The demand for power bank rises as electronic devices comes with low battery capacity. Longer duration usage of smart phone, increased demand of smart phone and increased usage of tablets has spurred the market growth of power bank globally. Functionality of electronic devices are increasing, propelling power bank market. Smart phone battery life has been a problem for consumer. This constraint has become opportunity for power bank companies. Safety is a concern as low grade power cells can be volatile based if overcharged in case of lithium-ion battery.

China is the important player in the power bank market, increasing demand across the world is increasing opportunities globally. Cell phones are sweeping the developing world as the technology become cheap. Growth of power bank market will increasingly rely on emerging market as Western Europe, Japan and North America reach saturation. Power bank is expected to attain success in developing nation where the power grid is lacking.

Some of the global players in power bank market are BYD Battery Company Limited, Energizer Holding INC, LG Chem Power Inc., Philips, Sony Corporation, Lishen, Buffalo Technology, Samsung Electronics, Ultralife Corporation and Sanyo among others. Research & developments and innovations are adopted by the companies as the strategies to rise in the power bank market.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America
  • Asia Pacific
  • Europe
  • Rest of the World

This report provides comprehensive analysis of
  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Read More Reports on Technology & Media Market:


About us

Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Inquiry Before Buying @ 



Contact Us

Mr. Atil Chaudhari
Corporate Office:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States.

Tel: +1-518-618-1030

Browse market research blog: